EUVIMEDEUVIMED entdecken
Crossref

Targeting ATRX-Deficient Hepatoblastoma

N Razizadeh, S Demir, H Scherthan, S Cairo, R Kappler

Klinische Pädiatrie · 01.05.2024 · 236 (03) · 211-212

DOI: 10.1055/s-0044-1786610 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Klinische Pädiatrie, erschienen am 01.05.2024. Verfasst von N Razizadeh und 4 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hepatoblastoma (HB) is the most common pediatric liver tumor. HB is genetically a very simple cancer with an average of only 3.4 mutations per tumor. New exome sequencing data on a larger series of aggressive cases revealed new candidate genes associated with an increased mutation number and chromosomal instability. One prominent candidate is the alpha thalassemia/mental retardation syndrome X-linked (ATRX) gene, for which loss of function is known to trigger rampant signs of genomic instability. To investigate the role of ATRX mutation in HB, we utilized the CRISPR-Cas9 system to functionally inactivate the ATRX gene in HB cell lines. Compared to wild-type cells, ATRX-deficient cell lines show reduced proliferation and compromised DNA repair capacities. RNA sequencing of mutant cells has provided insight into the molecular mechanisms of ATRX deficiency in HB. Using bioinformatics tools, this data is used to predict drugs specifically targeting ATRX-deficient HB. This study will contribute to our understanding of hypermutated aggressive HB and may lead to treatments specifically tailored to these patients. Publication History Article published online: 10 May 2024 © 2024. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany

Zitieren

APA

Razizadeh, N., Demir, S., Scherthan, H., Cairo, S., & Kappler, R. (2024). Targeting ATRX-Deficient Hepatoblastoma. Klinische Pädiatrie, 236(03), 211-212. https://doi.org/10.1055/s-0044-1786610

Vancouver

Razizadeh N, Demir S, Scherthan H, Cairo S, Kappler R. Targeting ATRX-Deficient Hepatoblastoma. Klinische Pädiatrie. 2024;236(03):211-212. doi:10.1055/s-0044-1786610

BibTeX
@article{Razizadeh2024,
  author = {Razizadeh, N and Demir, S and Scherthan, H and Cairo, S and Kappler, R},
  title = {Targeting ATRX-Deficient Hepatoblastoma},
  journal = {Klinische Pädiatrie},
  year = {2024},
  volume = {236},
  number = {03},
  pages = {211--212},
  doi = {10.1055/s-0044-1786610}
}
Kostenlos starten →